Sunscreen innovation is getting a major upgrade. The U.S. Food and Drug Administration has approved bemotrizinol--also known as BEMT and sold under the name PARSOL® Shield--the first new sunscreen filter cleared in 27 years.
Why This Matters
For decades, sunscreen formulas in the U.S. have relied on a familiar set of UV filters. While effective, many products still struggle with texture, leaving behind a white cast, a heavy feel, or eye irritation. BEMT is designed to change that by offering a lighter, oil-soluble option that spreads smoothly and works well on sensitive skin.
One of its biggest strengths is broad-spectrum coverage. BEMT helps protect against both UVB rays, which are linked to sunburn, and UVA rays, which penetrate deeper into the skin and contribute to premature aging. The ingredient has already been widely used in Europe and Asia, where next-generation sunscreen textures have become more common.
A Long Road to Approval
Because sunscreen is regulated as a drug in the U.S., new UV filters must go through a detailed review process. According to dermatologist Joshua Zeichner, MD, that process can take years. DSM-Firmenich, the company behind BEMT, says it has worked toward U.S. approval since 2002, making this milestone the result of more than two decades of development.
Industry observers say the ingredient could help reshape daily sun care by making protection feel more wearable and more intuitive. Neutrogena has also confirmed plans to bring BEMT into its future sunscreen pipeline, signaling that broader product launches may follow.
For consumers, the shift could be especially meaningful as skincare continues to move toward formulas that combine comfort, performance, and simplicity. If the new ingredient reaches shelves widely, it may help make daily SPF use feel less like a chore and more like a seamless habit. The future of sun protection may be lighter, smarter, and easier to embrace.
